Skip to content

A Clinical Trial on Effectiveness and Safety of Hydrogen Generator to Treat Dyspnea for the Patients With Tracheal Stenosis: A Randomized, Double-blind and Single-center Clinical Study

A Clinical Trial on Effectiveness and Safety of Inhaling Hydrogen-oxygen to Decreases Inspiratory Effort for the Patients With Tracheal Stenosis: A Randomized, Double-blind and Single-center Clinical Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02961387
Enrollment
50
Registered
2016-11-11
Start date
2016-11-30
Completion date
2018-06-30
Last updated
2016-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheal Stenosis

Keywords

Tracheal stenosis, Hydrogen generator, Hydrogen-oxygen, Dyspnea.

Brief summary

Investigators aim to study the effectiveness and safety of inhaling hydrogen-oxygen which produced by a hydrogen generator with nebulizer to decreases inspiratory effort for the patients with tracheal stenosis.

Interventions

DEVICEHydrogen generator treatment

The patients mainly used the hydrogen generator with nebulizer for inhalation of hydrogen-oxygen mixed gas.

DEVICEOxygen-making machine treatment

The patients mainly used medical molecular sieve oxygen-making machine for oxygen inhalation.

Sponsors

Guangzhou Institute of Respiratory Disease
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Aged from 18 to 65; 2. Diagnosed moderate/severe tracheal stenosis by chest CT and/or bronchoscopy; 3. Difficulty breathing symptoms 4. Agree to participate in this trial and sign the informed consent form.

Exclusion criteria

1. Those who were suffered from respiratory failure or more severe caused by dyspnea; 2. Combined other serious systemic diseases (severe arrhythmia, acute myocardial ischemia, uncontrollable hypertension crisis, active gastric ulcer, uncontrolled diabetes, renal failure, blood system diseases or coagulation dysfunction); 3. Those who were suffered from severe mental illness or could not take care of themselves; 4. Pregnant or lactating women; 5. Those who could not understand the trial procedures and correctly the trial equipment; 6. Those who participated in other clinical trials in the first 3 months before the screening date. Quit criteria 1. The subjects requiring emergency intubation or other intervention or surgical treatment due to worsened tracheal stenosis; 2. Subjects who had severe adverse events during treatment; 3. Subjects who did not want to continue to participate in the trial; 4. The subjects who were necessarily terminated for the trial by the investigators.

Design outcomes

Primary

MeasureTime frameDescription
Change in sRMSdi/para/sc, RMSdi, Pdi& MIP from baseline after inhalation by bench study.Baseline, 10min, 20min, 30min, 40min, 50min, 90min and 150minsRMSdi/para/sc: root-mean-square of diaphragm/parasternal/sternocleidomastoid surface electromyography; RMSdi: root-mean-square of diaphragm electromyography; Pdi: Transdiaphragmatic pressure; MIP:maximal inspiratory pressure.

Secondary

MeasureTime frameDescription
Change in symptom of dyspnea from baseline after inhalation.Baseline, 10min, 20min, 30min, 40min, 50min, 90min and 150minChanges in comfort with each gas mixture were evaluated by a simple questionnaire
Change in signs(BR, HR, BP, el) from baseline after inhalationBaseline, 10min, 20min, 30min, 40min, 50min, 90min and 150minChange in signs include breath rate, heart rate, blood pressure,Three Depression Sign and so on.
Change in PaO2, PaCO2, PH& HCO3- after inhalationBaseline and 150minChange in Arterial blood gases.
Change in Borg score for dyspnea after inhalation.Baseline, 10min, 20min, 30min, 40min, 50min, 90min and 150min
Change in impulse oscillometry variables(R5,R20,X5,AX,RF) as change from baseline when inhaling.Baseline and inhalingR5 - Resistance at 5Hz, R20 - Resistance at 20Hz, X5 - Reactance at 5Hz, RF - Frequency of resonance, AX - Area under reactance curve
Change in cough waves from baseline when inhalingBaseline, Inhaling.Cough waves will be recorded by a voice recorder.
Grades of airway stenosis by bronchoscopybaseline
FEV1 & FVCBaselineForced expiratory volume in one second & Forced vital capacity.

Countries

China

Contacts

Primary ContactZiqing Zhou, Doctor
zhou.ziqing@foxmail.com+86 13535580261

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026